{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:58:38Z","timestamp":1791979118685,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH.100-001739"],"award-info":[{"award-number":["NTUH.100-001739"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["103-2410-H-004 -014"],"award-info":[{"award-number":["103-2410-H-004 -014"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["104-2314-B-002 -103 -MY3"],"award-info":[{"award-number":["104-2314-B-002 -103 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["104-2314-B-002 -109 -MY3"],"award-info":[{"award-number":["104-2314-B-002 -109 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.cmi.2016.07.018","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T07:19:24Z","timestamp":1469690364000},"page":"890.e1-890.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose"],"prefix":"10.1016","volume":"22","author":[{"given":"Y.-C.","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2016.07.018_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200003093421007","article-title":"Vancomycin-resistant enterococcal infections","volume":"342","author":"Murray","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2016.07.018_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"8575\u20136","key":"10.1016\/j.cmi.2016.07.018_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","article-title":"Vancomycin-resistant enterococci","volume":"1","author":"Uttley","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2016.07.018_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2016.07.018_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/14656560902811811","article-title":"Therapeutic options for infections due to vancomycin-resistant enterococci","volume":"10","author":"Wang","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cmi.2016.07.018_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-138-2-200301210-00015","article-title":"Linezolid: the first oxazolidinone antimicrobial","volume":"138","author":"Moellering","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2016.07.018_bib7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In\u00a0vitro activities of daptomycin, vancomycin, linezolid, and quinupristin\u2013dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2016.07.018_bib8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of Veterans Affairs patients","volume":"61","author":"Britt","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2016.07.018_bib9","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1128\/AAC.00714-13","article-title":"Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections","volume":"57","author":"Whang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2016.07.018_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01289-13","article-title":"Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia","volume":"58","author":"Balli","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2016.07.018_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/IPC.0b013e31827ce847","article-title":"Treatment of vancomycin-resistant enterococcal bacteremia in an observational cohort of neutropenic oncology patients daptomycin versus linezolid","volume":"21","author":"Barbour","year":"2013","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.cmi.2016.07.018_bib12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.clinthera.2010.09.008","article-title":"Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: a retrospective, multicenter, cohort study","volume":"32","author":"Crank","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.cmi.2016.07.018_bib13","first-page":"1969","article-title":"Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients","volume":"19","author":"Kraft","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cmi.2016.07.018_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/dkp154","article-title":"Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?","volume":"64","author":"Mave","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2016.07.018_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1017\/S0950268810002475","article-title":"Observational study of the epidemiology and outcomes of vancomycin-resistant enterococcus bacteraemia treated with newer antimicrobial agents","volume":"139","author":"McKinnell","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2016.07.018_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jhm.994","article-title":"Vancomycin-resistant enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin","volume":"7","author":"Twilla","year":"2012","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.cmi.2016.07.018_bib17","first-page":"205","article-title":"Daptomycin","volume":"55","author":"Enoch","year":"2007","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2016.07.018_bib18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1592\/phco.29.7.792","article-title":"Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients","volume":"29","author":"Gallagher","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2016.07.018_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12879-014-0687-9","article-title":"Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis","volume":"14","author":"Chuang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2016.07.018_bib20","series-title":"Performance standards for antimicrobial susceptibility testing: 20th informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"10.1016\/j.cmi.2016.07.018_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care\u2013associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2016.07.018_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.cmi.2016.07.018_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for Gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2016.07.018_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2334-13-66","article-title":"Safety and efficacy of high-dose daptomycin as salvage therapy for severe Gram-positive bacterial sepsis in hospitalized adult patients","volume":"13","author":"Lai","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2016.07.018_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.cmi.2016.07.018_bib26","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1186\/cc10262","article-title":"A\u00a0comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance","volume":"15","author":"Baptista","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2016.07.018_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02294361","article-title":"Model selection and Akaike's information criterion (AIC): the general theory and its analytical extensions","volume":"52","author":"Bozdogan","year":"1987","journal-title":"Psychometrika"},{"key":"10.1016\/j.cmi.2016.07.018_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/096228029500400302","article-title":"Generalized additive models for medical research","volume":"4","author":"Hastie","year":"1995","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.cmi.2016.07.018_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.cmi.2016.07.018_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/46.4.523","article-title":"Development of daptomycin for Gram-positive infections","volume":"46","author":"Tally","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2016.07.018_bib31","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1128\/AAC.06439-11","article-title":"Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant enterococcus isolates in an in\u00a0vitro pharmacokinetic\/pharmacodynamic model with simulated endocardial vegetations","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2016.07.018_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/IPC.0b013e31822b7f6e","article-title":"Comparison of linezolid and daptomycin in the treatment of vancomycin-resistant enterococcal bacteremia","volume":"19","author":"Bio","year":"2011","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.cmi.2016.07.018_bib33","unstructured":"Dubrovskaya Y, Kubin CJ, Furuya EY, Paper presented at the 46th annual meeting of the Infectious Diseases Society of America, 2008, abstract K-3443."},{"key":"10.1016\/j.cmi.2016.07.018_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/13543784.2013.766716","article-title":"Weight-adjusted versus fixed dose of linezolid for chinese healthy volunteers of higher and lower body weight: a phase I pharmacokinetic and pharmacodynamic study","volume":"22","author":"Cai","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.cmi.2016.07.018_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmii.2011.11.005","article-title":"Emergence of vancomycin-resistant enterococcus bloodstream infections in southern taiwan","volume":"45","author":"Chou","year":"2012","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2016.07.018_bib36","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/jac\/dks181","article-title":"Microbiological and clinical characteristics of vancomycin-resistant enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis","volume":"67","author":"Lu","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2016.07.018_bib37","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/civ449","article-title":"Editorial commentary: linezolid vs. daptomycin for vancomycin-resistant enterococci: the evidence gap between trials and clinical experience","volume":"61","author":"McKinnell","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2016.07.018_bib38","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1128\/AAC.00526-13","article-title":"Multicenter study of high-dose daptomycin for treatment of enterococcal infections","volume":"57","author":"Casapao","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2016.07.018_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/600039","article-title":"Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program","volume":"49","author":"Figueroa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2016.07.018_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1592\/phco.31.6.527","article-title":"High-dose daptomycin for treatment of complicated Gram-positive infections: a large, multicenter, retrospective study","volume":"31","author":"Kullar","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2016.07.018_bib41","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/AAC.44.11.2948-2953.2000","article-title":"Once-daily dosing in dogs optimizes daptomycin safety","volume":"44","author":"Oleson","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16302427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16302427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:20:38Z","timestamp":1761117638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X16302427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1198743X16302427"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2016.07.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726591136.793540638","asserted-by":"object"}]},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2016.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}